KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
48 hedge funds and large institutions have $101M invested in Kindred Biosciences, Inc. in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $96K
Holders
48
Holding in Top 10
–
Calls
–
Puts
$96K
Top Buyers
| 1 | +$16.9M | |
| 2 | +$1.76M | |
| 3 | +$1.6M | |
| 4 |
Renaissance Technologies
New York
|
+$1.08M |
| 5 |
BlackRock
New York
|
+$695K |
Top Sellers
| 1 | -$6.8M | |
| 2 | -$468K | |
| 3 | -$326K | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$185K |
| 5 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$161K |